Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zizheng Xiao, Yiwen Mo, Wen Long, Ruping Li, Xinling Li, Yuan Wei, Wei Fan & Xu Zhang. (2021) Value of baseline and end of chemotherapy 18F-FDG PET/CT in pediatric patients with Burkitt lymphoma. Leukemia & Lymphoma 62:12, pages 2873-2881.
Read now
Read now
Volkan Hazar, Vural Kesik, Gülsün Tezcan Karasu, Gülyüz Öztürk, Alphan Küpesiz, Suar Çakı Kılıç, Erman Ataş, Vedat Uygun, Nurşah Eker, Fatih Erbey, Şebnem Yılmaz Bengoa, Suna Emir, Sema Anak, Haldun Öniz, Hayriye Daloğlu, Serap Aksoylar, Ülker Koçak, Musa Karakükçü, Murat Elli, Nilgün Kurucu & Akif Yeşilipek. (2018) Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry. Leukemia & Lymphoma 59:1, pages 85-96.
Read now
Read now
Anna Kieslich, Peter Ruf, Horst Lindhofer, Raynold Buhmann, Angelika Eggert & Patrick Hundsdoerfer. (2017) Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease. Leukemia & Lymphoma 58:8, pages 1989-1992.
Read now
Read now
Jennifer Worch, Marius Rohde & Birgit Burkhardt. (2013) Mature B-Cell Lymphoma and Leukemia in Children and Adolescents—Review of Standard Chemotherapy Regimen and Perspectives. Pediatric Hematology and Oncology 30:6, pages 465-483.
Read now
Read now
Articles from other publishers (33)
Samah F. Semary, Hany Abdel Rahman, Naglaa Elkinaai, Iman Zaky, Nouran Nagy, Sherine Salem & Asmaa Hamoda. (2023) Prognostic Factors and Treatment Outcome of Relapsing and Refractory Pediatric Mature B-cell Non-Hodgkin Lymphoma, Children’s Cancer Hospital Egypt Experience. Journal of Pediatric Hematology/Oncology 45:6, pages e757-e763.
Crossref
Crossref
Cristina López, Birgit Burkhardt, John K. C. Chan, Lorenzo Leoncini, Sam M. Mbulaiteye, Martin D. Ogwang, Jackson Orem, Rosemary Rochford, Mark Roschewski & Reiner Siebert. (2022) Burkitt lymphoma. Nature Reviews Disease Primers 8:1.
Crossref
Crossref
Alexander M. Newman, Masood Zaka, Peixun Zhou, Alex E. Blain, Amy Erhorn, Amy Barnard, Rachel E. Crossland, Sarah Wilkinson, Amir Enshaei, Julian De Zordi, Fiona Harding, Mary Taj, Katrina M. Wood, Despina Televantou, Suzanne D. Turner, G. A. Amos Burke, Christine J. Harrison, Simon Bomken, Chris M. Bacon & Vikki Rand. (2021) Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia 36:3, pages 781-789.
Crossref
Crossref
Ying LiuBiping Deng, Bo HuWenqun ZhangQing ZhuYang LiuShan WangPei ZhangYing YangJunhan YangQinlong ZhengXinjian YuZifen GaoChunju ZhouWei HanJing YangLing JinChunrong Tong, Alex H. Chang & Yonghong Zhang. (2022) Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma. Blood Advances 6:3, pages 717-730.
Crossref
Crossref
Fabio Timeus, Matilde Piglione, Franca Fagioli & Aldo Ravaglia. (2021) Linfoma di Burkitt in età pediatrica. Medico e Bambino pagine elettroniche 24:6, pages 175-184.
Crossref
Crossref
Sebastian Zahnreich & Heinz Schmidberger. (2021) Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies. Cancers 13:11, pages 2607.
Crossref
Crossref
A. V. Kozlov, I. V. Kazantsev, T. V. Yukhta, P. S. Tolkunova, A. G. Gevorgyan, I. Yu. Nikolayev, A. N. Galibin, O. I. Bogdanova, D. A. Zvyagintseva, M. S. Golenkova, O. S. Yudintseva, U. V. Sviridova, A. N. Shvetsov, V. V. Baykov, E. V. Babenko, M. A. Estrina, Yu. A. Punanov, E. V. Morozova, A. D. Kulagin, N. B. Mikhaylova & L. S. Zubarovskaya. (2021) High-dose polychemotherapy with autologous hematopoietic stem cell transplantation in children with non-Hodgkin lymphomas. Pediatric Hematology/Oncology and Immunopathology 20:2, pages 53-64.
Crossref
Crossref
Birgit Burkhardt, Mary Taj, Nathalie Garnier, Veronique Minard-Colin, Volkan Hazar, Karin Mellgren, Tomoo Osumi, Alina Fedorova, Natalia Myakova, Jaime Verdu-Amoros, Mara Andres, Edita Kabickova, Andishe Attarbaschi, Alan Kwok Shing Chiang, Eva Bubanska, Svetlana Donska, Lisa Lyngsie Hjalgrim, Jacek Wachowiak, Anna Pieczonka, Anne Uyttebroeck, Jelena Lazic, Jan Loeffen, Jochen Buechner, Felix Niggli, Monika Csoka, Gergely Krivan, Julia Palma, G. A. Amos Burke, Auke Beishuizen, Kristin Koeppen, Stephanie Mueller, Heidi Herbrueggen, Wilhelm Woessmann, Martin Zimmermann, Adriana Balduzzi & Marta Pillon. (2021) Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations. Cancers 13:9, pages 2075.
Crossref
Crossref
Xueqian Li, Meng Zhou, Jiaqian Qi & Yue Han. (2021) Efficacy and Safety of Inotuzumab Ozogamicin (CMC-544) for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 21:3, pages e227-e247.
Crossref
Crossref
Emily M. Hsieh & Rayne H. Rouce. (2020) Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphoma. Hematology 2020:1, pages 487-493.
Crossref
Crossref
Paul D. Harker-Murray, Lauren Pommert & Matthew J. Barth. (2020) Novel Therapies Potentially Available for Pediatric B-Cell Non-Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network 18:8, pages 1125-1134.
Crossref
Crossref
Kimberly DaviesMatthew BarthSaro ArmenianAnthony N. AudinoPhillip BarnetteBranko CuglievanHilda DingJames B. FordPaul J. GalardyRebecca GardnerRabi HannaRobert HayashiAlexandra E. KovachAndrea Judit MachnitzKelly W. MaloneyLianna MarksKristin PageAnne F. ReillyJoanna L. WeinsteinAna C. Xavier, Nicole R. McMillian & Deborah A. Freedman-Cass. (2020) Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:8, pages 1105-1123.
Crossref
Crossref
Maria L. Moleti, Anna M. Testi & Robin Foà. (2020) Treatment of relapsed/refractory paediatric aggressive B‐cell non‐Hodgkin lymphoma. British Journal of Haematology 189:5, pages 826-843.
Crossref
Crossref
Wilhelm Woessmann, Martin Zimmermann, Andrea Meinhardt, Stephanie Mueller, Holger Hauch, Fabian Knörr, Ilske Oschlies, Wolfram Klapper, Felix Niggli, Edita Kabickova, Andishe Attarbaschi, Alfred Reiter & Birgit Burkhardt. (2020) Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy. Blood.
Crossref
Crossref
Reiji Fukano. 2020. Pediatric Acute Lymphoblastic Leukemia. Pediatric Acute Lymphoblastic Leukemia
73
80
.
Charlotte Rigaud, Anne Auperin, Anne Jourdain, Stephanie Haouy, Marie‐Laure Couec, Nathalie Aladjidi, Virginie Gandemer, Anne Lambliotte, Geneviève Plat, Judith Landman‐Parker, Jean Michon, Thierry Leblanc, Catherine Patte & Veronique Minard‐Colin. (2019) Outcome of relapse in children and adolescents with B‐cell non‐Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study. Pediatric Blood & Cancer 66:9.
Crossref
Crossref
Naoto Fujita, Ryoji Kobayashi, Yoshiko Atsuta, Fuminori Iwasaki, Junji Suzumiya, Yoji Sasahara, Masami Inoue, Katsuyoshi Koh, Tsukasa Hori, Hiroaki Goto, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Ritsuro Suzuki & Tetsuo Mitsui. (2019) Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma. International Journal of Hematology 109:4, pages 483-490.
Crossref
Crossref
Paul C. Nathan, Karin P. S. Langenberg-Ververgaert & Noelle Cullinan. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
353
366
.
Amos Burke, Joerg Krueger & Birte Wistinghausen. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
315
335
.
Tetsuya Mori & Tomoo Osumi. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
305
313
.
Rakesh Kumar MauryaBirte Wistinghausen & Birgit Burkhardt. 2019. Reciprocating Engine Combustion Diagnostics. Reciprocating Engine Combustion Diagnostics
245
282
.
Mitchell Cairo, Anne Auperin, Sherrie L. Perkins, Ross Pinkerton, Lauren Harrison, Stanton Goldman & Catherine Patte. (2018) Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group. British Journal of Haematology 182:6, pages 859-869.
Crossref
Crossref
Gerald J. Draper, John F. Bithell, Kathryn J. Bunch, Gerald M. Kendall, Michael F. G. Murphy & Charles A. Stiller. (2018) Childhood cancer research in Oxford II: The Childhood Cancer Research Group. British Journal of Cancer 119:6, pages 763-770.
Crossref
Crossref
Tony H. Truong, Sarah Alexander & Sheila Weitzman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
975
998
.
Nicholas J. Short, Hagop M. Kantarjian, Heidi Ko, Joseph D. Khoury, Farhad Ravandi, Deborah A. Thomas, Guillermo Garcia‐Manero, Maria Khouri, Jorge E. Cortes, William G. Wierda, Srdan Verstovsek, Zeev Estrov, Alessandra Ferrajoli, Philip A. Thompson, Sherry Pierce, Susan M. O'Brien & Elias Jabbour. (2017) Outcomes of adults with relapsed or refractory Burkitt and high‐grade B‐cell leukemia/lymphoma. American Journal of Hematology 92:6.
Crossref
Crossref
Tomoo Osumi, Tetsuya Mori, Naoto Fujita, Akiko M. Saito, Atsuko Nakazawa, Masahito Tsurusawa & Ryoji Kobayashi. (2016) Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatric Blood & Cancer 63:10, pages 1794-1799.
Crossref
Crossref
Francesco Ceppi, Sheila Weitzman, Wilhelm Woessmann, Kimberly Davies, Alvaro Lassaletta, Bettina Reismüller, Karin Mellgren, Anne Uyttebroeck, Iris Maia, Shaker Abdullah, Natasha Miakova, Darryl Glaser, Richard Cohn, Oussama Abla, Andishe Attarbaschi & Sarah Alexander. (2016)
Safety and efficacy of intrathecal rituximab in children with
B
cell lymphoid CD20+ malignancies: An international retrospective study
. American Journal of Hematology 91:5, pages 486-491.
Crossref
Crossref
Véronique Minard-ColinLaurence BrugièresAlfred ReiterMitchell S. CairoThomas G. GrossWilhelm WoessmannBirgit BurkhardtJohn T. SandlundDenise WilliamsMarta PillonKeizo HoribeAnne AuperinMarie-Cécile Le DeleyMartin ZimmermanSherrie L. PerkinsMartine RaphaelLaurence LamantWolfram KlapperLara MussolinHélène A. PoirelElizabeth MacintyreChristine Damm-WelkAngelo RosolenCatherine Patte. (2015) Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead. Journal of Clinical Oncology 33:27, pages 2963-2974.
Crossref
Crossref
Friedhelm R. Schuster, Michael Stanglmaier, Wilhelm Woessmann, Beate Winkler, Meinolf Siepermann, Roland Meisel, Paul G. Schlegel, Jürgen Hess, Horst Lindhofer, Arndt Borkhardt & Raymund Buhmann. (2015) Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies. British Journal of Haematology 169:1, pages 90-102.
Crossref
Crossref
Annelies van Vuren & Friederike Meyer-Wentrup. (2014) New targets for antibody therapy of pediatric B cell lymphomas. Pediatric Blood & Cancer 61:12, pages 2158-2163.
Crossref
Crossref
Hyery Kim, Eun Sil Park, Soo Hyun Lee, Hong Hoe Koo, Hyo Sun Kim, Chuhl Joo Lyu, So Eun Jun, Young Tak Lim, Hee Jo Baek, Hoon Kook, Ji Won Lee, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin & Hyeo Seop Ahn. (2014) Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents. Cancer Research and Treatment 46:4, pages 358-365.
Crossref
Crossref
Lidija Dokmanovic. (2013) Biomarkers in childhood non-Hodgkin’s lymphomas. Biomarkers in Medicine 7:5, pages 791-801.
Crossref
Crossref
Wilhelm Woessmann. (2013) XI. How to treat children and adolescents with relapsed non-Hodgkin lymphoma?. Hematological Oncology 31:S1, pages 64-68.
Crossref
Crossref